Sensitization of mesenteric afferents to chemical and mechanical stimuli following systemic bacterial lipopolysaccharide

Neurogastroenterol Motil. 2005 Feb;17(1):89-101. doi: 10.1111/j.1365-2982.2004.00585.x.

Abstract

Backgrounds and aims: The mechanisms underlying endotoxin-induced hyperalgesia remain unknown. We aimed to study the mechanisms underlying the sensitizing action of lipopolysaccharide (LPS) on intestinal afferent responses to mechanical and chemical stimuli.

Methods: Extracellular recordings of jejunal afferent nerve discharge were obtained from pentobarbitone-anaesthetized rats.

Results: Lipopolysaccharide (6 mg kg(-1), i.v.) stimulated a short-term, transient (<30 min) increase in chemosensitivity to systemic 5-HT (6 microg kg(-1)) and responses to mechanical distension and a delayed but maintained (>30 min) increase in spontaneous afferent discharge. Naproxen (10 mg kg(-1)) and the prostaglandin receptor antagonist AH6809 (1 mg kg(-1)) significantly attenuated both the short-term sensitization to mechanical distension and 5-HT and the long-term increase in baseline afferent firing following LPS. In contrast, the iNOS inhibitor aminoguanidine (15 mg kg(-1)) and the L-type calcium channel antagonist nifedipine (1 mg kg(-1)) both prolonged the period of afferent sensitization to distension and 5-HT without influencing the augmented baseline-firing rate. omega-Conotoxin GVIA attenuated the increase in afferent discharge to LPS, without any change in mechano- and chemosensitivity.

Conclusions: The long-term (>30 min) increase in afferent firing following systemic LPS involves neurogenic release of prostanoids. The short-term (<30 min) sensitization also appears to depend on prostanoid release, while nitric oxide production may serve to down-regulate LPS-induced afferent hypersensitivity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Animals
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Guanidines / pharmacology
  • Hemodynamics / drug effects
  • Lipopolysaccharides / pharmacology*
  • Male
  • Mesentery / drug effects
  • Mesentery / innervation*
  • Naproxen / pharmacology
  • Neurons, Afferent / drug effects*
  • Neurons, Afferent / physiology*
  • Nifedipine / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type II
  • Physical Stimulation
  • Prostaglandin Antagonists / pharmacology
  • Prostaglandins / metabolism
  • Rats
  • Serotonin / pharmacology
  • Serotonin Antagonists / pharmacology
  • Stimulation, Chemical
  • Xanthones / pharmacology
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Calcium Channel Blockers
  • Cyclooxygenase Inhibitors
  • Guanidines
  • Lipopolysaccharides
  • Prostaglandin Antagonists
  • Prostaglandins
  • Serotonin Antagonists
  • Xanthones
  • Serotonin
  • 6-isopropoxy-9-oxoxanthene-2-carboxylic acid
  • Naproxen
  • omega-Conotoxin GVIA
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Nifedipine
  • pimagedine